ABIOMED, Inc. (NASDAQ:ABMD) shares fell -0.26% in last trading session and ended the day at $102.03. ABMD Gross Margin is 84.60% and its has a return on assets of 34.60%. ABIOMED, Inc. (NASDAQ:ABMD) quarterly performance is 17.79%.
ABIOMED, Inc. (NASDAQ:ABMD) announced that on Tuesday, May 3, 2016, the Company will release financial results for the fourth quarter of fiscal 2016. The Company will host a conference call to discuss the results on Tuesday, May 3, 2016, at 8:00 a.m. EDT.
On 26 April, General Electric Company (NYSE:GE) shares increased 0.72% and was closed at $30.90. GE EPS growth in last 5 year was -32.00%. General Electric Company (NYSE:GE) year to date (YTD) performance is -0.01%.
General Electric Company (NYSE:GE) declared a $0.23 per share dividend on the outstanding common stock of the Company payable April 25, 2016 to shareowners of record at the close of business on February 29, 2016. The ex-dividend date is February 25, 2016.
Johnson & Johnson (NYSE:JNJ) shares fell -0.53% in last trading session and ended the day at $112.91. JNJ Gross Margin is 69.30%. Johnson & Johnson (NYSE:JNJ) quarterly performance is 12.40%.
Johnson & Johnson (NYSE:JNJ) will participate in the 2016 Deutsche Bank 41st Annual Health Care Conference on Thursday, May 5, at The InterContinental Boston. Dr. William Hait, MD. PhD, Global Head Janssen Research & Development, LLC will represent the Company in a session scheduled at 10:40 a.m. (Eastern Time).
ServiceNow, Inc. (NYSE:NOW) caters to the Technology space. It has a net profit margin of -43.10% and weekly performance is 14.12%. On the last day of trading company shares ended up at $72.66. ServiceNow, Inc. (NYSE:NOW) distance from 50-day simple moving average (SMA50) is 19.64%.
On April 20, 2016, ServiceNow, Inc. (NYSE:NOW) reported a loss of $333.3 million in its first quarter.The Santa Clara, California-based company said it had a loss of $2.06 per share. Earnings, adjusted for one-time gains and costs, came to 9 cents per share.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) caters to the Healthcare space. It has a net profit margin of 8.00% and weekly performance is -2.05%. On the last day of trading company shares ended up at $55.50. Teva Pharmaceutical Industries Limited (NYSE:TEVA) distance from 50-day simple moving average (SMA50) is -0.74%.
Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA)‘s stock had its “outperform” rating reiterated by equities researchers at RBC Capital in a research report issued on Wednesday, Marketbeat reports. They presently have a $75.00 price objective on the stock, up from their previous price objective of $73.00. RBC Capital’s target price would suggest a potential upside of 31.00% from the company’s current price.